Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaushal Jerajani

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biomaterials|April 13, 2018
Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agentsJaydev R Upponi, Kaushal Jerajani, Dattatri K Nagesha, et al.
Vaccines|June 27, 2024
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt AdjuvantRia T Caringal, John M Hickey, Nitya Sharma, et al.
Journal of Pharmaceutical Sciences|December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability StudiesNitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Journal of Pharmaceutical Sciences|September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative CombinationsKaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences|August 1, 2022
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation DevelopmentKaushal Jerajani, Ying Wan, John M Hickey, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biomaterials|April 13, 2018
Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agentsJaydev R Upponi, Kaushal Jerajani, Dattatri K Nagesha, et al.
Vaccines|June 27, 2024
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt AdjuvantRia T Caringal, John M Hickey, Nitya Sharma, et al.
Journal of Pharmaceutical Sciences|December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability StudiesNitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Journal of Pharmaceutical Sciences|September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative CombinationsKaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences|August 1, 2022
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation DevelopmentKaushal Jerajani, Ying Wan, John M Hickey, et al.
Pageof 1